Follow the ONCOLYTICS BIOTECH INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was reported on 13 March 2026 (Acquisition). Among the most active insiders: Kelly Jared. Every trade is accessible without an account.
12
Insider Decl.
0
Thresholds
€258,152
12 ops.
Buy Volume
·
0 ops.
Sell Volume
51Σ signal
Buys €258,152· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
100,000 shares@ US$1.037768.2% of flowCommon SharesSEC:0001493152-26-002879:0
Ideal exit: 13 Oct 2026 (T+270)
12 of 12 declarations
About ONCOLYTICS BIOTECH INC
ONCOLYTICS BIOTECH INC is a biopharmaceutical company focused on developing cancer treatments using oncolytic viruses. The company is listed on NASDAQ under the ticker ONCY.